Total and differential leukocyte counts as predictors of ischemic heart disease: The caerphilly and speedwell studies

American Journal of Epidemiology

Volumn 145, Issue 5, 1997, Pages 416-421

  Sweetnam, Peter M ^a   Thomas, Hugh F ^a   Yarnell, John W G ^b   Baker, Ian A ^c   Elwood, Peter C ^a  

^a LLANDOUGH HOSPITAL   (United Kingdom)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^c Bristol District Health Authority   (United Kingdom)

Author keywords

eosinophils; leukocyte count; myocardial ischemia; neutrophils; smoking

Indexed keywords

ADULT; ARTICLE; EOSINOPHIL; HUMAN; ISCHEMIC HEART DISEASE; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL; RISK ASSESSMENT; RISK FACTOR; SMOKING;

EID: 0031049639     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.aje.a009123     Document Type: Article

References (20)

1. Friedman GD, Klatksy AL, Siegelaub AB. The leukocyte count as a predictor of myocardial infarction. N Engl J Med 1974;290:1275-8.
2. Zalokar J, Richard JL, Claude JR. Leukocyte count, smoking, and myocardial infarction. N Engl J Med 1981;304:465-8.
3. Prentice RL, Szatrowski TP, Fujikura T, et al. Leukocyte counts and coronary heart disease in a Japanese cohort. Am J Epidemiol 1982;116:496-509.
4. Grimm RH, Neaton JD, Ludwig W. Prognostic importance of the white blood cell count for coronary, cancer, and all-cause mortality. JAMA 1985;254:1932-7.
5. Yarnell JWG, Baker IA, Sweetnam PM, et al. Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease: the Caerphilly and Speedwell collaborative heart disease studies. Circulation 1991;83:836-44.
6. Kannel WB, Anderson K, Wilson PWF. White blood cell count and cardiovascular disease. Insights from the Framingham Study. JAMA 1992;267:1253-6.
7. Corre F, Lellouch J, Schwartz D. Smoking and leucocyte counts. Results of an epidemiological survey. Lancet 1971;2:632-4.
8. Yarnell JWG, Sweetnam PM, Rogers S, et al. Some long term effects of smoking on the haemostatic system: a report from the Caerphilly and Speedwell collaborative surveys. J Clin Pathol 1987;40:909-13.
9. Phillips AN, Neaton JD, Cook DG, et al. Leukocyte counts and risk of major coronary heart disease events. Am J Epidemiol 1992;136:59-70.
10. Olivares R, Ducimetière P, Claude JR. Monocyte count: a risk factor for coronary heart disease? Am J Epidemiol 1993;137:49-53.
11. Rose GA, Blackburn H. Cardiovascular survey methods. Geneva: World Health Organization, 1968.
12. World Health Organization Regional Office for Europe. Myocardial infarction community registers. Copenhagen: World Health Organization, 1976. (Public health in Europe, no. 5).
13. Bainton D, Baker IA, Sweetnam PM, et al. Prevalence of ischaemic heart disease: the Caerphilly and Speedwell surveys. Br Heart J 1988;59:201-6.
14. Shaper AG, Cook DG, Walker M, et al. Prevalence of ischaemic heart disease in British men. Br Heart J 1984;51:595-605.
15. Pocock SJ, Shaper AG, Phillips AN. Concentrations of high density lipoprotein cholesterol, triglycerides and total cholesterol in ischaemic heart disease. BMJ 1989;298:998-1002.
16. Kannel WB, Wolf PA, Castelli WP, et al. Fibrinogen and risk of cardiovascular disease. The Framingham Study. JAMA 1987;258:1183-6.
17. Ernst E, Hammerschmidt DE, Bagge U, et al. Leukocytes and the risk of ischemic diseases. JAMA 1987;257:2318-24.
18. Yarnell JWG, Evans A. Chlamydia and coronary heart disease. Eur Heart J 1996;17:650-1.
19. Ensrud K, Grimm RH. The white blood cell count and risk for coronary heart disease. Am Heart J 1992;124:207-13.
20. Roitt IM, Brostoff J, Male DK. Immunology. London: Gower, 1985.